HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
ADMA
Adma Biologics Inc
Healthcare Biotechnology · New Jersey, USA · Reports in usd
Market Cap: $2.06B
Market Cap
$2.06B
Enterprise Val
$2.12B
P/E Ratio
12.43
P/B Ratio
5.27
Trailing PEG (1Y)
0.17
As Of
May 18, 2026

Overview & Key Metrics

Reporting period: Mar 31, 2026 · Q1 2026
Book Value$390.3M
Gross Margin70.53%
Profit Margin70.53%
Return on Equity38.97%
Return on Assets27.37%
Current Ratio6.95
Debt/Equity0.51
LT Debt/Equity0.50
Revenue Per Share0.48

Income Statement

Mar 31, 2026
Revenue$114.5M
Cost of Revenue$33.7M
Gross Profit$80.8M
R&D$2.6M
SG&A$26.7M
Operating Expenses$22.5M
Operating Income$58.3M
Interest Expense$2.1M
Tax Expense$11.8M
Net Income$45.3M
EPS (Basic)$0.19
EPS (Diluted)$0.19
EBIT$59.2M
EBITDA$61.1M
Consolidated Income$45.3M
Non-Controlling Interests$0.00

Balance Sheet

Mar 31, 2026
Cash & Equivalents$138.2M
Accounts Receivable$135.9M
Inventory$222.1M
Current Assets$511.2M
LT Investments$0.00
Property, Plant & Equipment$71.4M
Intangibles$4.2M
Non-Current Assets$154.0M
Total Assets$665.2M
Accounts Payable$20.5M
Current Debt$4.5M
Current Liabilities$73.5M
LT Debt$193.6M
Non-Current Liabilities$201.3M
Total Liabilities$274.9M
Total Debt$198.0M
Retained Earnings-$116.3M
Shareholder Equity$390.3M
Shares Outstanding238,159,176

Cash Flow Statement

Mar 31, 2026
Operating Cash Flow$58.2M
Investing Cash Flow$2.4M
Financing Cash Flow-$10.1M
CapEx-$2.5M
Free Cash Flow$55.7M
Depreciation & Amort.$1.8M
Stock-Based Comp$6.3M
Acquisitions / Disposals$5.0M
Investment Activity$0.00
Debt Issued/Repaid$124.5M
Equity Issued/Repaid-$129.6M
Dividends Paid$0.00
Net Change in Cash$50.5M
Data cached · Meta live · Daily live · Statements live · TTL 24h